These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6280565)

  • 21. Clinical electrophysiology in myasthenia gravis.
    Stalberg E
    J Neurol Neurosurg Psychiatry; 1980 Jul; 43(7):622-33. PubMed ID: 6249895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuromusclar junction and myasthenic crisis.
    Mayer RF; Albuquerque EX; Rash JE; Hudson CS
    Trans Am Neurol Assoc; 1977; 102():100-4. PubMed ID: 616082
    [No Abstract]   [Full Text] [Related]  

  • 23. On the release of transmitter at normal, myasthenia gravis and myasthenic syndrome affected human end-plates.
    Cull-Candy SG; Miledi R; Trautmann A; Uchitel OD
    J Physiol; 1980 Feb; 299():621-38. PubMed ID: 6103954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pathophysiology of neuromuscular transmission disturbances].
    Elmqvist D
    Nord Med; 1971 Dec; 86(48):1442. PubMed ID: 4332385
    [No Abstract]   [Full Text] [Related]  

  • 25. Jitter analysis with concentric needle electrode in the masseter muscle for the diagnosis of generalised myasthenia gravis.
    Orhan EK; Deymeer F; Oflazer P; Parman Y; Baslo MB
    Clin Neurophysiol; 2013 Nov; 124(11):2277-82. PubMed ID: 23849701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Passive transfer of human myasthenia gravis to rats: 1. Electrophysiology of the developing neuromuscular block.
    Howard JF; Sanders DB
    Neurology; 1980 Jul; 30(7 Pt 1):760-4. PubMed ID: 7190241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
    Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
    Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative electrophysiology and pharmacology of mammalian (including one marsupial) intercostal muscle biopsy preparations.
    Bowen JM
    Am J Vet Res; 1975 Nov; 36(11):1619-22. PubMed ID: 1190605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of passive transfer of myasthenic serum on mechanical, electrical and neuromuscular transmission properties of mouse skeletal muscle.
    Losavio A; Muchnik S; Panizza M; Sica RE; Jauregui WO
    Medicina (B Aires); 1989; 49(1):7-13. PubMed ID: 2561004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [On the impaired neuromuscular transmission in myasthenia gravis].
    Kruckenberg P; Pontzen W; Sandweg R; Bauer H
    Z Neurol; 1971; 200(2):158-73. PubMed ID: 4108119
    [No Abstract]   [Full Text] [Related]  

  • 31. Neuromuscular transmission in myasthenia gravis studied with single fibre electromyography.
    Stålberg E; Ekstedt J; Broman A
    J Neurol Neurosurg Psychiatry; 1974 May; 37(5):540-7. PubMed ID: 4366058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acetylcholine release in myasthenia gravis: regulation at single end-plate level.
    Plomp JJ; Van Kempen GT; De Baets MB; Graus YM; Kuks JB; Molenaar PC
    Ann Neurol; 1995 May; 37(5):627-36. PubMed ID: 7755358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of myasthenic immunoglobulin G on neuromuscular transmission in mouse diaphragm.
    Chiu HC; Chen ML; Tsai MC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Aug; 20(3):217-23. PubMed ID: 2827968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Miniature end-plate potentials in neuromuscular disease: an electrophysiological investigation of motor-point muscle biopsies.
    Haynes J
    J Neurol Neurosurg Psychiatry; 1971 Oct; 34(5):521-6. PubMed ID: 5122379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The neuromuscular blocking effects of therapeutic concentrations of various antibiotics on normal rat skeletal muscle: a quantitative comparison.
    Caputy AJ; Kim YI; Sanders DB
    J Pharmacol Exp Ther; 1981 May; 217(2):369-78. PubMed ID: 6112258
    [No Abstract]   [Full Text] [Related]  

  • 36. Experimental autoimmune myasthenia gravis: a sequential and quantitative study of the neuromuscular junction ultrastructure and electrophysiologic correlations.
    Engel AG; Tsujihata M; Lambert EH; Lindstrom JM; Lennon VA
    J Neuropathol Exp Neurol; 1976; 35(5):569-87. PubMed ID: 956872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuromuscular transmission in neonatal mice injected with serum globulin of myasthenia gravis patients.
    Pagala MK; Tada S; Namba T; Grob D
    Neurology; 1982 Jan; 32(1):12-7. PubMed ID: 6275304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pre- and postjunctional blocking effects of aminoglycoside, polymyxin, tetracycline and lincosamide antibiotics.
    Singh YN; Marshall IG; Harvey AL
    Br J Anaesth; 1982 Dec; 54(12):1295-306. PubMed ID: 6293521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myasthenic syndrome: effect of choline, plasmapheresis and tests for circulating factor.
    Kranz H; Caddy DJ; Williams AM; Gay W
    J Neurol Neurosurg Psychiatry; 1980 Jun; 43(6):483-8. PubMed ID: 6110709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disorders of neuromuscular transmission other than myasthenia gravis.
    Swift TR
    Muscle Nerve; 1981; 4(4):334-53. PubMed ID: 6114428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.